United States Of America to India: Vati Import Trade Route
India has recorded 1 verified shipments of Vati imported from United States Of America, representing a combined trade value of $10.0K USD. This corridor is served by 1 active United States Of America exporters, with an average shipment value of $10.0K USD. The leading United States Of America supplier is SHARP CLINICAL SERVICES LLC, which accounts for 100% of total import value with 1 shipments worth $10.0K USD. On the buying side, PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT is the largest Indian importer with $10.0K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The United States Of America to India Vati corridor is one of India's established pharmaceutical import routes from United States Of America, with 1 shipments documented worth a combined $10.0K USD. The route is dominated by SHARP CLINICAL SERVICES LLC, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of United States Of America's vati export sector.
Across 1 active United States Of America suppliers, the average shipment value stands at $10.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with vati's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 12.9%, placing it at rank #12 among India's top vati import origins globally.
On the Indian buyer side, key Indian importers include PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT. PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT is the single largest Indian importer with 1 shipments valued at $10.0K USD.
